{"id":"https://openalex.org/W1958311435","doi":"https://doi.org/10.1093/cid/civ637","title":"Immunization Costs and Programmatic Barriers at an Urban HIV Clinic","display_name":"Immunization Costs and Programmatic Barriers at an Urban HIV Clinic","publication_year":2015,"publication_date":"2015-07-29","ids":{"openalex":"https://openalex.org/W1958311435","doi":"https://doi.org/10.1093/cid/civ637","mag":"1958311435","pmid":"https://pubmed.ncbi.nlm.nih.gov/26224001","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/6276886"},"language":"en","primary_location":{"id":"doi:10.1093/cid/civ637","doi":"https://doi.org/10.1093/cid/civ637","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/civ637","pdf_url":"https://academic.oup.com/cid/article-pdf/61/11/1726/16788983/civ637.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://academic.oup.com/cid/article-pdf/61/11/1726/16788983/civ637.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085516894","display_name":"Ellen Eaton","orcid":"https://orcid.org/0000-0001-8539-4907","observed_orcids":["https://orcid.org/0000-0001-8539-4907"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Ellen F. Eaton","raw_affiliation_strings":["1 Infectious Disease"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Infectious Disease","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030237510","display_name":"Andrzej Kulczycki","orcid":"https://orcid.org/0000-0001-9659-4488","observed_orcids":["https://orcid.org/0000-0001-9659-4488"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andrzej Kulczycki","raw_affiliation_strings":["2 Ryals School of Public Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2 Ryals School of Public Health","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066136225","display_name":"Michael S. Saag","orcid":"https://orcid.org/0000-0002-8866-1043","observed_orcids":["https://orcid.org/0000-0002-8866-1043"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Saag","raw_affiliation_strings":["1 Infectious Disease"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Infectious Disease","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032398444","display_name":"Michael J. Mugavero","orcid":"https://orcid.org/0000-0001-6916-6701","observed_orcids":["https://orcid.org/0000-0001-6916-6701"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Mugavero","raw_affiliation_strings":["1 Infectious Disease"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1 Infectious Disease","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5049766813","display_name":"James Luther Raper","orcid":"https://orcid.org/0000-0002-3242-4911","observed_orcids":["https://orcid.org/0000-0002-3242-4911"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James L. Raper","raw_affiliation_strings":["University of Alabama at Birmingham 3"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham 3","institution_ids":["https://openalex.org/I32389192"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5085516894"],"corresponding_institution_ids":[],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":2.7246,"has_fulltext":true,"cited_by_count":9,"citation_normalized_percentile":{"value":0.89240175,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"61","issue":"11","first_page":"1726","last_page":"1731"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.4867999851703644,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","score":0.4867999851703644,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.23520000278949738,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.1185000017285347,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv","display_name":"HIV","score":0.5669999718666077},{"id":"https://openalex.org/keywords/vaccine-cost","display_name":"vaccine cost","score":0.765999972820282},{"id":"https://openalex.org/keywords/vaccine-reimbursement","display_name":"vaccine reimbursement","score":0.8339999914169312},{"id":"https://openalex.org/keywords/gardasil","display_name":"Gardasil","score":0.8309999704360962},{"id":"https://openalex.org/keywords/prevnar","display_name":"Prevnar","score":0.9729999899864197},{"id":"https://openalex.org/keywords/zostavax","display_name":"Zostavax","score":1.0},{"id":"https://openalex.org/keywords/vaccine-uptake","display_name":"vaccine uptake","score":0.5899999737739563},{"id":"https://openalex.org/keywords/uninsured-patients","display_name":"uninsured patients","score":0.7749999761581421},{"id":"https://openalex.org/keywords/affordable-care-act","display_name":"Affordable Care Act","score":0.8270000219345093},{"id":"https://openalex.org/keywords/insurance-coverage","display_name":"insurance coverage","score":0.6690000295639038},{"id":"https://openalex.org/keywords/advisory-committee-on-immunization-practices-recommendations","display_name":"Advisory Committee on Immunization Practices recommendations","score":0.824999988079071},{"id":"https://openalex.org/keywords/urban-hiv-clinic","display_name":"urban HIV clinic","score":0.8330000042915344}],"concepts":[{"id":"https://openalex.org/C2779703844","wikidata":"https://www.wikidata.org/wiki/Q760125","display_name":"Reimbursement","level":3,"score":0.8370459079742432},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8230321407318115},{"id":"https://openalex.org/C2776534028","wikidata":"https://www.wikidata.org/wiki/Q1141363","display_name":"Medicaid","level":3,"score":0.677146315574646},{"id":"https://openalex.org/C22070199","wikidata":"https://www.wikidata.org/wiki/Q192995","display_name":"Vaccination","level":2,"score":0.6228001713752747},{"id":"https://openalex.org/C195487862","wikidata":"https://www.wikidata.org/wiki/Q850210","display_name":"Revenue","level":2,"score":0.5021705627441406},{"id":"https://openalex.org/C2780801004","wikidata":"https://www.wikidata.org/wiki/Q1415366","display_name":"Immunization","level":3,"score":0.4979877471923828},{"id":"https://openalex.org/C512399662","wikidata":"https://www.wikidata.org/wiki/Q3505712","display_name":"Family medicine","level":1,"score":0.4712021052837372},{"id":"https://openalex.org/C160735492","wikidata":"https://www.wikidata.org/wiki/Q31207","display_name":"Health care","level":2,"score":0.45415937900543213},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.1859203279018402},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.13367325067520142},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.12777501344680786},{"id":"https://openalex.org/C50522688","wikidata":"https://www.wikidata.org/wiki/Q189833","display_name":"Economic growth","level":1,"score":0.0},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.0},{"id":"https://openalex.org/C147483822","wikidata":"https://www.wikidata.org/wiki/Q103537","display_name":"Antigen","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068857","descriptor_name":"Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000069443","descriptor_name":"Heptavalent Pneumococcal Conjugate Vaccine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000554","descriptor_name":"Ambulatory Care Facilities","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D003365","descriptor_name":"Costs and Cost Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007114","descriptor_name":"Immunization","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012051","descriptor_name":"Reimbursement Mechanisms","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D019458","descriptor_name":"Insurance Coverage","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D053061","descriptor_name":"Herpes Zoster Vaccine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D058991","descriptor_name":"Patient Protection and Affordable Care Act","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1093/cid/civ637","doi":"https://doi.org/10.1093/cid/civ637","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/civ637","pdf_url":"https://academic.oup.com/cid/article-pdf/61/11/1726/16788983/civ637.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:5254058","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/pmc/articles/PMC6276886","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:6276886","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/6276886","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Infect Dis","raw_type":"Text"},{"id":"pmid:26224001","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/26224001","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/cid/civ637","doi":"https://doi.org/10.1093/cid/civ637","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/civ637","pdf_url":"https://academic.oup.com/cid/article-pdf/61/11/1726/16788983/civ637.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G1474431243","display_name":null,"funder_award_id":"L30 AI120000","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G2833378591","display_name":"UAB K12 IN PATIENT CENTERED OUTCOMES RESEARCH","funder_award_id":"K12HS023009","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"},{"id":"https://openalex.org/G5709402805","display_name":"UAB HEALTH SERVICES & OUTCOMES RESEARCH TRAINING PROGRAM","funder_award_id":"T32HS013852","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"},{"id":"https://openalex.org/G7066807305","display_name":null,"funder_award_id":"HS013852","funder_id":"https://openalex.org/F4320332177","funder_display_name":"Agency for Healthcare Research and Quality"}],"funders":[{"id":"https://openalex.org/F4320332177","display_name":"Agency for Healthcare Research and Quality","ror":"https://ror.org/03jmfdf59"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1958311435.pdf","grobid_xml":"https://content.openalex.org/works/W1958311435.grobid-xml"},"referenced_works_count":22,"referenced_works":["https://openalex.org/W252068646","https://openalex.org/W1814405991","https://openalex.org/W1973103249","https://openalex.org/W1996050196","https://openalex.org/W1997936519","https://openalex.org/W2006862605","https://openalex.org/W2020565892","https://openalex.org/W2038507666","https://openalex.org/W2043933094","https://openalex.org/W2093246726","https://openalex.org/W2107615304","https://openalex.org/W2147519428","https://openalex.org/W2163434103","https://openalex.org/W2182809315","https://openalex.org/W2189263758","https://openalex.org/W2411887292","https://openalex.org/W2412651542","https://openalex.org/W2609514493","https://openalex.org/W4235614583","https://openalex.org/W4249915502","https://openalex.org/W4297691726","https://openalex.org/W6687273811"],"related_works":["https://openalex.org/W2589124388","https://openalex.org/W2922098076","https://openalex.org/W3011489157","https://openalex.org/W2543440925","https://openalex.org/W7148295496","https://openalex.org/W2111888273","https://openalex.org/W2941757224","https://openalex.org/W2127301109","https://openalex.org/W2043424560","https://openalex.org/W2951388850"],"abstract_inverted_index":{"BACKGROUND:":[0],"Although":[1],"the":[2,18,189],"increasing":[3],"number":[4],"of":[5,22,41,90,154,158,168,180,188,209,221],"recommended":[6],"immunizations":[7,24],"is":[8],"essential":[9],"for":[10,29,80,144,172,186,225,261],"patients":[11,49,111,231],"infected":[12],"with":[13,123,218],"human":[14],"immunodeficiency":[15],"virus":[16],"(HIV),":[17],"potentially":[19],"uncompensated":[20],"costs":[21,40],"expanded":[23],"will":[25],"present":[26],"significant":[27],"challenges":[28],"clinics":[30],"and":[31,45,70,82,98,134,248,265],"health":[32,249],"systems":[33,250],"serving":[34],"HIV-infected":[35],"patients.":[36],"METHODS:":[37],"We":[38],"estimated":[39],"providing":[42],"Gardasil,":[43],"Prevnar,":[44],"Zostavax":[46],"to":[47,102,130,164,176,192,199,252],"eligible":[48,230],"at":[50],"a":[51,165],"US":[52],"Ryan":[53,202],"White":[54,203],"Part":[55],"C":[56],"academically":[57],"affiliated":[58],"HIV":[59,227,263],"clinic":[60,178,194,228],"in":[61,126,215,234],"2013.":[62],"Clinic":[63],"expenditures":[64],"were":[65,86],"calculated":[66,75,143],"using":[67,76],"vaccine":[68],"price":[69],"administrative":[71],"fees.":[72],"Revenue":[73],"was":[74,142,148],"insurance":[77,107,133,216],"reimbursement":[78,100,128,185,200,241],"data":[79],"vaccination":[81],"administration.":[83],"Three":[84],"scenarios":[85],"used:":[87],"100%":[88],"uptake":[89,93,174],"vaccines,":[91],"adjusted":[92,99],"based":[94],"on":[95,256],"published":[96],"rates,":[97],"according":[101],"pre-Affordable":[103],"Care":[104],"Act":[105],"(ACA)":[106],"status.":[108],"RESULTS:":[109],"2887":[110],"(27%":[112],"Medicare,":[113],"13%":[114],"Alabama":[115],"Medicaid,":[116],"26%":[117],"Commercial,":[118],"34%":[119],"Uninsured),":[120],"received":[121,232],"care":[122],"wide":[124],"variation":[125,214],"immunization":[127,187,259],"($0":[129],"$210)":[131],"by":[132],"vaccine.":[135,146],"The":[136],"net":[137,152,166],"yield":[138,153,167],"(revenue":[139],"minus":[140],"expenditure)":[141],"each":[145],"Prevnar":[147],"most":[149],"costly:":[150],"annual":[151,177],"-$60":[155],"691.":[156],"Provision":[157],"all":[159],"3":[160,210],"vaccines":[161,211],"would":[162],"lead":[163],"-$97":[169],"122.":[170],"Adjusting":[171],"reduced":[173,193],"led":[175,191],"losses":[179,195,220],"$44":[181],"119.":[182],"Using":[183],"pre-ACA":[184],"uninsured":[190],"(-$62":[196],"326),":[197],"attributable":[198],"via":[201],"funds.":[204],"CONCLUSIONS:":[205],"A":[206],"cost":[207,239],"analysis":[208],"shows":[212],"great":[213],"coverage,":[217],"potential":[219],"almost":[222],"$100":[223],"000":[224],"one":[226,235],"if":[229,245],"vaccinations":[233],"calendar":[236],"year.":[237],"Adequate,":[238],"neutral":[240],"should":[242],"be":[243],"instituted":[244],"medical":[246],"providers":[247],"are":[251],"achieve":[253],"Advisory":[254],"Committee":[255],"Immunization":[257],"Practices":[258],"recommendations":[260],"both":[262],"positive":[264],"negative":[266],"adults.":[267]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}